期刊文献+

不同化疗药物用药模式治疗老年急性髓性白血病临床护理研究 被引量:1

Clinical nursing research on the treatment of elderly patients with acute myeloid leukemia with different chemotherapeutic drugs
下载PDF
导出
摘要 目的:探讨不同化疗方案治疗老年急性髓性白血病时的临床护理要点。方法:选择我院在2014年1月—2015年12月期间收治的急性髓性白血病老年患者60例,根据化疗方案不同分为阿糖胞苷,阿克拉霉素联用粒细胞集落刺激因子(CAG)方案组和司莫司汀,艾诺宁加阿糖胞苷(MIA)方案组,各30例,在治疗过程中做好患者护理工作,比较两组患者治疗缓解率和不良反应发生情况。结果:CAG组患者治疗总有效率显著高于MIA组(86.67%VS 63.34%,P<0.05),两组患者主要不良反应发生情况比较无显著差异(P>0.05)。结论:CAG方案治疗老年MIA效果更佳,针对不同的不良反应实施良好护理是化疗成功的基础。 Objective: To explore the nursing points of different chemotherapy regimens in the treatment of elderly patients with acute myeloidleukemia. Methods: 60 elderly patients with acute myeloid leukemia who were admitted to our hospital from January 2014 to December 2015 weredivided into CAG group and MIA group according to the different chemotherapy regimens, each of the 30 cases. Do a good job in the treatmentof patients with nursing. Comparison of two groups of patients in the treatment of remission rate and the incidence of adverse reactions wasperformed. Results: The total effective rate of patients in group CAG was significantly higher than that in group MIA (86.67% vs 63.34%, P<0.05).There was no significant difference in the incidence of major side effects between the two groups (P>0.05). Conclusion: CAG regimen in thetreatment of elderly MIA effect is better. And implementation of good nursing to deal with different adverse reactions is the basis of the success ofchemotherapy.
作者 程秋野 CHEN Qiu-ye(Department of hematology, People's Hospital, Pingxiang Jiangxi 337000, China)
出处 《药品评价》 CAS 2016年第22期50-51,60,共3页 Drug Evaluation
关键词 急性髓性白血病 老年 化疗 护理 Acute Myeloid Leukemia Ederly Chemotherapy Nursing
  • 相关文献

参考文献7

二级参考文献87

  • 1贺丹军.前言——老年抑郁与躯体疾病的研究进展[J].实用老年医学,2013,27(7):531-531. 被引量:1
  • 2方亚晖,马俊霞,裴仁治.左旋门冬酰胺酶治疗急性淋巴细胞白血病不良反应观察[J].儿科药学杂志,2006,12(1):21-22. 被引量:3
  • 3肖爱军,陈素萍,时敏秀.全程心理管理程序在恶性肿瘤患者心理护理中的应用[J].护理学报,2007,14(6):83-85. 被引量:46
  • 4Sean C Sweetman .Martindale:The Complete Drug Reference [M].The Pharmaceutical Press,2007:506,592,610.
  • 5国家药典委员会.临床用药须知[M].2005版.北京:人民卫生出版社,2005:649-650.
  • 6Cunningham D,Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinote-can in irinotecan-refractory metastatic colorectal cancer [J]. N Engl J Med, 2004, 351: 337-345.
  • 7张之南,沈悌.血液病渗断与疗效标准[M].第3版.北京:科学技术出版社,1999:131-134.
  • 8王学文.老年人白血病的特征.国外医学:老年医学分册,1983,(2).
  • 9阎玲.白血病口腔感染的观察及护理.中华中西医药杂志,2010,10(3):43-44.
  • 10Laubach J, Rao AV. Current and emerging strategies for the management of acute myeloid leukemia in the elderly [J]. Oncologist, 2008, 13 (10): 1097-1108.

共引文献118

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部